High serum TGF-α levels in SSc patients with significant esophageal dysmotility: implications for improved treatment (CROSBI ID 683242)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Lalovac, M ; Martinovic Kaliterna, D ; Mejić Krstulovic, S ; Salamunic, I ; Perkovic, D ; Radic, M ; Markovic, V
engleski
High serum TGF-α levels in SSc patients with significant esophageal dysmotility: implications for improved treatment
Serum TGF-α levels are significantly higher in patients with SSc and may be new serum marker important for diagnosis and staging of this disease. Consequently, novel approach to the treatment of this disease may arise in the future.
TGF-α levels, esophageal dysmotility, Systemic sclerosis
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
82-83.
2012.
objavljeno
Podaci o matičnoj publikaciji
Rheumatology Oxford
Podaci o skupu
2nd Systemic Sclerosis world congress
poster
02.02.2012-04.02.2012
Madrid, Španjolska
